202 related articles for article (PubMed ID: 21178278)
1. Epidermodysplasia verruciformis and susceptibility to HPV.
Patel T; Morrison LK; Rady P; Tyring S
Dis Markers; 2010; 29(3-4):199-206. PubMed ID: 21178278
[TBL] [Abstract][Full Text] [Related]
2. Epidermodysplasia verruciformis and human papilloma virus.
Gewirtzman A; Bartlett B; Tyring S
Curr Opin Infect Dis; 2008 Apr; 21(2):141-6. PubMed ID: 18317036
[TBL] [Abstract][Full Text] [Related]
3. Epidermodysplasia verruciformis.
Burger B; Itin PH
Curr Probl Dermatol; 2014; 45():123-31. PubMed ID: 24643182
[TBL] [Abstract][Full Text] [Related]
4. [Pathogenesis of human papillomavirus infection in patients with epidermodysplasia verruciformis].
Liang S; Zuo YG; Wang BX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):93-6. PubMed ID: 19317070
[TBL] [Abstract][Full Text] [Related]
5. Epidermodysplasia verruciformis associated with HPV 10.
Zahir A; Craig L; Rady P; Tyring S; Ehrlich A
Dermatol Online J; 2013 Apr; 19(4):2. PubMed ID: 24021362
[TBL] [Abstract][Full Text] [Related]
6. Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.
McDermott DF; Gammon B; Snijders PJ; Mbata I; Phifer B; Howland Hartley A; Lee CC; Murphy PM; Hwang ST
Pediatr Dermatol; 2009; 26(3):306-10. PubMed ID: 19706093
[TBL] [Abstract][Full Text] [Related]
7. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses.
Orth G
Semin Immunol; 2006 Dec; 18(6):362-74. PubMed ID: 17011789
[TBL] [Abstract][Full Text] [Related]
8. CD8+ T-cell lymphocytopenia and lack of EVER mutations in a patient with clinically and virologically typical epidermodysplasia verruciformis.
Azzimonti B; Mondini M; De Andrea M; Gioia D; Dianzani U; Mesturini R; Leigheb G; Tiberio R; Landolfo S; Gariglio M
Arch Dermatol; 2005 Oct; 141(10):1323-5. PubMed ID: 16230580
[No Abstract] [Full Text] [Related]
9. Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. The Nambour Skin Cancer Prevention Study Group.
Boxman IL; Russell A; Mulder LH; Bavinck JN; Schegget JT; Green A
Int J Cancer; 2000 Apr; 86(1):118-21. PubMed ID: 10728604
[TBL] [Abstract][Full Text] [Related]
10. [HPV-5 typing with nested PCR and sequencing in epidermodysplasia verruciformis].
Schaller J; Rohwedder A; Fuchs M; Maron A; Kunze J
Hautarzt; 1996 Jun; 47(6):454-8. PubMed ID: 8767661
[TBL] [Abstract][Full Text] [Related]
11. The histologic spectrum of epidermodysplasia verruciformis in transplant and AIDS patients.
Morrison C; Eliezri Y; Magro C; Nuovo GJ
J Cutan Pathol; 2002 Sep; 29(8):480-9. PubMed ID: 12207742
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population.
Pfister H; Fuchs PG; Majewski S; Jablonska S; Pniewska I; Malejczyk M
Arch Dermatol Res; 2003 Dec; 295(7):273-9. PubMed ID: 14618345
[TBL] [Abstract][Full Text] [Related]
13. Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate.
Przybyszewska J; Zlotogorski A; Ramot Y
J Am Acad Dermatol; 2017 Jun; 76(6):1161-1175. PubMed ID: 28196644
[TBL] [Abstract][Full Text] [Related]
14. Novel TMC8 splice site mutation in epidermodysplasia verruciformis and review of HPV infections in patients with the disease.
Imahorn E; Yüksel Z; Spoerri I; Gürel G; Imhof C; Saraçoğlu ZN; Koku Aksu AE; Rady PL; Tyring SK; Kempf W; Itin PH; Burger B
J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1722-1726. PubMed ID: 28646613
[TBL] [Abstract][Full Text] [Related]
15. [The CXCL12/CXCR4 signaling pathway in the control of human papillomavirus infection: new susceptibility factors in viral pathogenesis].
Meuris F; Jaracz-Ros A; Gaudin F; Schlecht-Louf G; Deback C; Bachelerie F
Med Sci (Paris); 2017; 33(8-9):691-694. PubMed ID: 28945547
[No Abstract] [Full Text] [Related]
16. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis.
Orth G
Curr Top Microbiol Immunol; 2008; 321():59-83. PubMed ID: 18727487
[TBL] [Abstract][Full Text] [Related]
17. [Genetics and susceptibility to human papillomaviruses: epidermodysplasia verruciformis, a disease model].
Orth G
Bull Acad Natl Med; 2010 Jun; 194(6):923-40; discussion 941. PubMed ID: 21513129
[TBL] [Abstract][Full Text] [Related]
18. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations?
Majewski S; Jablonska S
Arch Dermatol; 2002 May; 138(5):649-54. PubMed ID: 12020228
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of p16 protein expression in squamous cell carcinomas from patients with epidermodysplasia verruciformis and patients without the disease.
Mattos MSG; Oliveira WR; Sotto MN
Arch Dermatol Res; 2017 Aug; 309(6):479-483. PubMed ID: 28439661
[TBL] [Abstract][Full Text] [Related]
20. A novel human papillomavirus identified in epidermodysplasia verruciformis.
Harris AJ; Purdie K; Leigh IM; Proby C; Burge S
Br J Dermatol; 1997 Apr; 136(4):587-91. PubMed ID: 9155964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
